326 results on '"Penson, Peter E."'
Search Results
2. Prevalence of statin intolerance: a meta-analysis
3. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
4. Patient experiences of their current asthma care and their views toward providing support for patients with asthma in community pharmacy: A Qualitative study
5. Supermarket/hypermarket opportunistic screening for atrial fibrillation (SHOPS-AF) using sensors embedded in the handles of supermarket trolleys: A feasibility study
6. Statin Intolerance: An Overview for Clinicians
7. Using Read-Across to build Physiologically-Based Kinetic models: Part 2. Case studies for atenolol and flumioxazin
8. Using read-across to build physiologically-based kinetic models: Part 1. Development of a KNIME workflow to assist analogue selection for PBK modelling
9. Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
10. Long-COVID-19: Definition, Epidemiology, and Clinical Implications
11. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
12. Could siRNA therapeutics change the way we treat dyslipidemia?
13. Integrated Care for Atrial Fibrillation Management: The Role of the Pharmacist
14. The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis
15. Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel
16. Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study
17. Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)
18. Management of Statin Intolerance
19. The management of asthma in adult patients in the community pharmacy setting: Literature review
20. Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry
21. Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes
22. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
23. A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome
24. Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches
25. Using Read-Across to Build Physiologically-Based Kinetic Models: Part 2. Case Studies for Atenolol and Flumioxazin
26. RNA Silencing in the Management of Dyslipidemias
27. Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies
28. Management of Statin Intolerance
29. Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003–18.
30. The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis
31. Therapeutic drug monitoring: applying the ‘Goldilocks Principle’ to clinical pharmacology
32. LDL-C: lower is better for longer—even at low risk
33. The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
34. Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies
35. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
36. Individualized therapy in statin intolerance: the key to success
37. Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity : an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies
38. Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies.
39. The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper.
40. Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018
41. Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study
42. Editorial commentary: Bacterial lipopolysaccharide–Stoking the fire of residual risk?
43. Adherence to statin therapy: it seems we know everything, yet we do nothing
44. Identifying and addressing pill aversion in adults without physiological‐related dysphagia: A narrative review
45. Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?
46. Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study Protocol
47. Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study.
48. Lecturing: A lost art
49. Homozygous familial hypercholesterolaemia: shedding new light on a rare but deadly condition
50. Warfarin—Is Self-Care the Best Care?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.